Surgical Stapler Injuries Result in FDA Warning for Certain Devices Used With da Vinci Robots

Warning follows years of surgical stapler lawsuits involving device malfunctions, which have resulted in internal bleeding, infections and emergency surgeries.

Federal health officials are warning surgeons and hospitals about a potential problem involving certain surgical staplers used with robotic surgery systems, cautioning that the issue may increase the risk of serious complications during procedures.

The U.S. Food and Drug Administration (FDA) issued an early alert concerning Intuitive Surgical stapling systems on March 18, indicating the agency is actively evaluating the issue and working with the manufacturer to better understand its scope and the potential risks to patients.

Surgical staplers are widely used to cut and seal tissue during a variety of procedures, including gastrointestinal, thoracic and bariatric surgeries. The devices are designed to simultaneously staple and divide tissue, helping reduce bleeding and shorten procedure times when functioning properly.

However, the FDA warns that a malfunction involving the stapler system could result in incomplete or failed staple lines, which may lead to serious complications such as internal bleeding, leakage at the surgical site or the need for additional corrective procedures.

The warning follows a number of prior surgical stapler lawsuits, where plaintiffs have raised claims that certain defective devices are prone to malfunction, leading led to serious injuries and deaths during routine procedures. Many of these complaints involve reports of misfires, malformed staples or failures similar to the risks outlined in the current warning.

Intuitive Surgical Stapler Warning

According to the FDA, Intuitive Surgical has received at least four reports of serious injuries and at least one death potentially associated with the recently recalled surgical stapler.

The issue may potentially affect how Intuitive Surgical stapler systems used with the company’s da Vinci robotic systems form staples or seal tissue. If staplers do not perform as intended, surgeons may be required to take additional steps during the procedure to manage the complication, which could increase surgical time and patient risk.

The FDA indicates it is continuing to review adverse event reports and other data related to the stapler system, and may take additional regulatory action if necessary.

In the meantime, healthcare providers are being advised to carefully review device instructions, monitor for any irregularities during use and report any problems or complications associated with the stapler system to Intuitive Surgical at customerservice@intusurg.com or 1-800-876-1310.

Adverse reactions or other quality problems may also be reported to MedWatch, the FDA’s safety information and adverse event reporting program. 

Surgical Stapler Concerns

The warning about Intuitive Surgical stapling systems comes amid longstanding safety concerns that have drawn increased regulatory scrutiny and litigation over the past decade.

In recent years, the FDA has received tens of thousands of adverse event reports involving surgical staplers and their components, including cases tied to serious injuries and deaths. Malfunctions can lead to severe complications such as uncontrolled bleeding, organ damage, sepsis, and the need for emergency surgical repair, often resulting in additional procedures or extended hospital stays.

Federal regulators have previously issued safety communications and updated guidance aimed at improving oversight, including reclassifying certain staplers to require more rigorous premarket review and enhanced adverse event reporting.

Patients who experienced complications during procedures involving surgical staplers may wish to seek medical evaluation and consider whether legal options, including a potential medical malpractice claim, are available.

Sign up for more safety and legal news that could affect you or your family.